Multicontrast MRI-based radiomics for the prediction of pathological complete response to neoadjuvant chemotherapy in patients with early triple negative breast cancer
Authors:
- 13 July 2021
- journal article
- research article
- Published by Springer Nature in Magnetic Resonance Materials in Physics, Biology and Medicine
- Vol. 34 (6) , 833-844
Abstract
Introduction To assess pre-therapeutic MRI-based radiomic analysis to predict the pathological complete response to neoadjuvant chemotherapy (NAC) in women with early triple negative breast cancer (TN). Materials and methods This monocentric retrospective study included 75 TN female patients with MRI (T1-weighted, T2-weighted, diffusion-weighted and dynamic contrast enhancement images) performed before NAC. For each patient, the tumor(s) and the parenchyma were independently segmented and analyzed with radiomic analysis to extract shape, size, and texture features. Several sets of features were realized based on the 4 different sequence images. Performances of 4 classifiers (random forest, multilayer perceptron, support vector machine (SVM) with linear or quadratic kernel) were compared based on pathological complete response (defined on the excised tissues), on 100 draws with 75% as training set and 25% as test. Results The combination of features extracted from different MR images improved the classifier performance (more precisely, the features from T1W, T2W and DWI). The SVM with quadratic kernel showed the best performance with a mean AUC of 0.83, a sensitivity of 0.85 and a specificity of 0.75 in the test set. Conclusion MRI-based radiomics may be relevant to predict NAC response in TN cancer. Our results promote the use of multi-contrast MRI sources for radiomics, providing enrich source of information to enhance model generalization.Keywords
Funding Information
- LabEx PRIMES (ANR-11-LABX-0063)
- LYRICAN (INCa_INSERM_DGOS_12563)
This publication has 35 references indexed in Scilit:
- Radiomics of Multiparametric MRI for Pretreatment Prediction of Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer: A Multicenter StudyClinical Cancer Research, 2019
- Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methodsInternational Journal of Cancer, 2018
- Neoadjuvant chemotherapy in breast cancer: more than just downsizingThe Lancet Oncology, 2018
- Neoadjuvant trials in early breast cancer: pathological response at surgery and correlation to longer term outcomes – what does it all mean?BMC Medicine, 2015
- Breast MRI: EUSOBI recommendations for women’s informationEuropean Radiology, 2015
- Radiomics: Extracting more information from medical images using advanced feature analysisEuropean Journal of Cancer, 2012
- Meta-analysis confirms achieving pathological complete response after neoadjuvant chemotherapy predicts favourable prognosis for breast cancer patientsEuropean Journal of Cancer, 2011
- Triple-Negative Breast CancerNew England Journal of Medicine, 2010
- Triple-Negative Breast Cancers: Unique Clinical Presentations and OutcomesAnnals of Surgical Oncology, 2010
- Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast CancerJournal of Clinical Oncology, 2008